This trial studies the use and experience of music therapy in cancer patients with delirium (a disturbance in mental abilities that results in confused thinking and reduced awareness) and the experience of music therapists working with these patients. Music therapy sessions are done at the patient’s bedside, where the music therapist plays live music on a guitar, keyboard, harp, or percussion instrument, sometimes as accompaniment to singing. Music therapy may improve physical and emotional symptoms such as pain, nausea, anxiety, and depression. Music therapy may also improve spiritual well-being and quality of life.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04104217.
PRIMARY OBJECTIVE:
I. To understand the experience, relevance, and clinical utility of music therapy with oncology patients with delirium.
OUTLINE:
Patients undergo music therapy per standard of care. Patients who recover from delirium, then complete interviews over 30-60 minutes each 1-6 days after resolution of delirium, and 3-12 days after first interview. Caregivers complete interviews over 30-60 minutes each within 3 days after each music therapy session. Music therapist completes interviews about the clinical process after the after initial and follow up music sessions. Nurses complete interviews over 10-15 minutes each after initial music therapy session.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationMemorial Sloan Kettering Cancer Center
Principal InvestigatorHolly Mentzer
